Quincke swelling - Causes, Treatment & When to See a Doctor

```html

What is Quincke swelling?

Quincke swelling, more commonly called angioedema, is a rapid, localized swelling of the deeper layers of the skin and mucous membranes. The swelling usually affects the face, lips, tongue, throat, eyes, or genitals, but it can involve any part of the body. Unlike a simple rash, the edema is sub‑dermal—meaning it occurs beneath the surface of the skin—so the skin looks smooth, firm, and often shiny.

The term “Quincke” honors Heinrich Quincke, a German physician who first described the condition in the late 1800s. Today, clinicians use “angioedema” to encompass both allergic and non‑allergic forms, and the condition may be acute (lasting hours to days) or chronic (recurrent episodes over months to years).

Common Causes

Angioedema can be triggered by many different mechanisms. Below are the most frequently encountered causes, grouped by category.

• IgE‑mediated food allergy – peanuts, tree nuts, shellfish, eggs, and dairy.
• Drug reactions – particularly ACE inhibitors (e.g., lisinopril, enalapril), NSAIDs, and certain antibiotics.
• Physical triggers – cold exposure, pressure, vibration, or sunlight (known as physical urticaria).
• Hereditary angioedema (HAE) – a rare genetic deficiency of C1‑esterase inhibitor.
• Acquired C1‑esterase inhibitor deficiency – usually associated with lymphoproliferative disorders or autoimmune disease.
• Infections – especially viral (e.g., hepatitis C, HIV) and bacterial sinus or dental infections.
• Autoimmune disorders – systemic lupus erythematosus, rheumatoid arthritis, and vasculitis.
• Hormonal changes – estrogen‑containing oral contraceptives or pregnancy can exacerbate angioedema.
• Stress & anxiety – can precipitate episodes in people with underlying mast‑cell hyper‑reactivity.
• Idiopathic – in up to 30 % of cases no clear trigger is identified.

Associated Symptoms

Because the swelling involves deeper tissue, the presentation often includes other signs that help differentiate angioedema from simple dermatitis or cellulitis.

• Burning, itching, or tingling sensation before the swelling appears.
• Swelling of the lips, eyelids, or periorbital area that may be asymmetrical.
• Glossal (tongue) edema that can impair speech or swallowing.
• Voice changes or a “tight‑throat” feeling.
• Difficulty breathing if the airway (pharynx or larynx) is involved.
• Urticaria (hives) – present in many allergic forms but absent in many hereditary cases.
• Gastrointestinal symptoms (abdominal pain, vomiting) in hereditary angioedema.
• Fever or erythema if an infection is the underlying trigger.

When to See a Doctor

While many episodes resolve on their own, certain situations warrant prompt medical evaluation:

• Swelling involves the tongue, floor of the mouth, or throat.
• Difficulty speaking, swallowing, or breathing.
• Rapid progression of swelling within minutes to an hour.
• Associated hives, especially if accompanied by wheezing or low blood pressure.
• Recurrent episodes without a clear trigger (to rule out hereditary or acquired C1‑esterase deficiency).
• Swelling after starting a new medication, especially an ACE inhibitor.
• Any swelling in a child under 2 years old, as pediatric airways are smaller.

Diagnosis

Diagnosing angioedema involves a combination of clinical assessment and targeted laboratory testing.

Clinical Evaluation

• Detailed history – onset, duration, suspected triggers, medication list, family history of angioedema.
• Physical exam – location and quality of swelling, presence of urticaria, airway assessment.

Laboratory & Specialty Tests

• C4 complement level – typically low in hereditary or acquired C1‑esterase inhibitor deficiency.
• C1‑esterase inhibitor (C1‑INH) quantity and function – distinguishes HAE type I (low quantity) from type II (dysfunctional protein).
• Complete blood count (CBC) and C‑reactive protein (CRP) – help rule out infection.
• Specific IgE testing or skin prick testing – if an allergic trigger is suspected.
• Drug‑challenge or withdrawal test – e.g., stopping an ACE inhibitor under supervision.
• Imaging (CT or neck X‑ray) – only if airway obstruction is suspected.

Differential Diagnosis

Conditions that can mimic angioedema include cellulitis, contact dermatitis, hereditary hemorrhagic telangiectasia, and neoplastic masses. Accurate diagnosis is essential because treatment pathways differ markedly.

Treatment Options

Treatment is guided by the underlying mechanism (allergic vs. bradykinin‑mediated) and severity of the episode.

Acute Management (First‑line)

• Airway protection – if there is any sign of airway compromise, call emergency services immediately. Endotracheal intubation or surgical airway may be required.
• Antihistamines – second‑generation H1 blockers (cetirizine 10 mg, loratadine 10 mg) for allergic forms; can be combined with H2 blockers (ranitidine or famotidine).
• Corticosteroids – oral prednisone 40–60 mg or IV methylprednisolone 125 mg for moderate‑severe allergic angioedema.
• Epinephrine – intramuscular auto‑injector (0.3 mg for adults) for cases with anaphylaxis or rapid progression.
• Bradykinin‑targeted therapy – for hereditary or ACE‑inhibitor–induced angioedema, use icatibant (a selective bradykinin B2 receptor antagonist) 30 mg subcutaneously, or ecallantide (a plasma kallikrein inhibitor) 30 mg subcutaneously. These are administered in an emergency department or under specialist supervision.

Chronic/Preventive Management

• Discontinue offending medication – switch from ACE inhibitors to angiotensin receptor blockers (ARBs) if blood‑pressure control is needed.
• Prophylactic medications for HAE –
  • Lanadelumab (subcutaneous monoclonal antibody) 300 mg every 2 weeks.
  • Berotralstat (oral kallikrein inhibitor) 150 mg daily.
• Antifibrinolytics – tranexamic acid 1–1.5 g three times daily can reduce frequency in some patients.
• Long‑acting antihistamines – may help if allergic triggers predominate.
• Lifestyle modifications – avoidance of known foods, temperature extremes, and stressors.

Home Care Measures

• Apply a cool compress to the affected area (never heat).
• Stay upright; lying flat can increase facial swelling.
• Maintain hydration; avoid alcohol and overly salty foods that can worsen edema.
• Keep an epinephrine auto‑injector on hand if you have a history of anaphylaxis.
• Document triggers in a diary to discuss with your healthcare provider.

Prevention Tips

While not all cases can be prevented, many strategies reduce the risk of recurrent episodes.

• Medication review – ask your doctor to assess the necessity of ACE inhibitors or NSAIDs if you have a history of angioedema.
• Allergen identification – undergo allergy testing and strictly avoid confirmed foods or insect stings.
• Vaccination – keep vaccinations up to date (e.g., influenza, COVID‑19) to lower infection‑related triggers.
• Stress management – regular exercise, mindfulness, or counseling can mitigate stress‑related episodes.
• Protective clothing – wear gloves, scarves, or warm hats in cold environments if you have cold‑induced angioedema.
• Carry emergency information – wear a medical alert bracelet indicating “Angioedema – may need epinephrine”.

Emergency Warning Signs

Key Take‑aways

Quincke swelling (angioedema) is a potentially serious condition that ranges from a mild, self‑limiting facial puffiness to life‑threatening airway obstruction. Understanding the triggers, recognizing early warning signs, and knowing when to seek urgent care can save lives. If you experience recurrent episodes, a thorough evaluation by an allergist or immunologist is essential to pinpoint the cause and establish a personalized prevention strategy.

References:

• Mayo Clinic. “Angioedema.” https://www.mayoclinic.org
• National Institute of Allergy and Infectious Diseases (NIAID). “Hereditary Angioedema.” https://www.niaid.nih.gov
• American College of Allergy, Asthma & Immunology. “Angioedema.” https://acaai.org
• Cleveland Clinic. “Management of Acute Angioedema.” https://my.clevelandclinic.org
• World Health Organization. “Guidelines for the Management of Anaphylaxis and Angioedema.” 2022.

```